METROPOLITAN LIFE INSURANCE CO/NY - THERAVANCE INC ownership

THERAVANCE INC's ticker is THRX and the CUSIP is 88338T104. A total of 152 filers reported holding THERAVANCE INC in Q2 2013. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.

Quarter-by-quarter ownership
METROPOLITAN LIFE INSURANCE CO/NY ownership history of THERAVANCE INC
ValueSharesWeighting
Q4 2015$638,000
+46.7%
60,5760.0%0.01%
+66.7%
Q3 2015$435,000
-60.3%
60,5760.0%0.00%
-62.5%
Q2 2015$1,095,000
+9.8%
60,576
-4.5%
0.01%
+14.3%
Q1 2015$997,000
+11.0%
63,4400.0%0.01%
+16.7%
Q4 2014$898,000
-17.2%
63,4400.0%0.01%
-25.0%
Q3 2014$1,084,000
-42.6%
63,4400.0%0.01%
-38.5%
Q2 2014$1,889,000
+1024.4%
63,440
+1071.3%
0.01%
+1200.0%
Q1 2014$168,000
-13.0%
5,4160.0%0.00%0.0%
Q4 2013$193,000
-12.7%
5,4160.0%0.00%
-50.0%
Q3 2013$221,000
+12.8%
5,416
+6.4%
0.00%0.0%
Q2 2013$196,0005,0880.00%
Other shareholders
THERAVANCE INC shareholders Q2 2013
NameSharesValueWeighting ↓
Baupost Group 16,538,977$637,247,00015.84%
Litespeed Management, L.L.C. 1,516,994$58,450,00010.69%
CHESAPEAKE PARTNERS MANAGEMENT CO INC/MD 2,584,469$99,580,0006.38%
Realm Partners LLC 166,061$6,398,0005.30%
IRIDIAN ASSET MANAGEMENT LLC/CT 10,000$385,300,0004.86%
SECTORAL ASSET MANAGEMENT INC 3,167,118$122,029,0003.61%
IRIDIAN ASSET MANAGEMENT LLC/CT 6,004,316$231,346,0002.92%
BB BIOTECH AG 888,244$34,224,0002.46%
Portolan Capital Management 163,617$6,304,0001.80%
Trellus Management Company, LLC 20,000$771,0000.98%
View complete list of THERAVANCE INC shareholders